Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions - Allergy, Asthma & Clinical Immunology
Source : https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00685-z
Background One of the main barriers to vaccination against SARS-CoV-2 is the fear of developing hypersensitivity reactions to any of its components. Although these reactions are very rare, it is necessary to establish an effective protocol to detect patients at risk of developing them.
Conclusions: Thanks to the allergological and immunohistochemical study, the vaccination protocol could be completed in about half of the patients who presented suspected hypersensitivity reactions to SARS-CoV-2 vaccines. IDTs with vaccines could be a valuable method for assessing the immunogenicity of the vaccines.